Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
EBF3 | hg38_v1_chr10_-_129964240_129964291 | 0.40 | 2.5e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_106335613 Show fit | 6.68 |
ENST00000603660.1
|
immunoglobulin heavy variable 3-30 |
|
chr2_-_89143133 Show fit | 4.18 |
ENST00000492167.1
|
immunoglobulin kappa variable 3-20 |
|
chr14_-_106269133 Show fit | 4.07 |
ENST00000390609.3
|
immunoglobulin heavy variable 3-23 |
|
chr14_-_106360320 Show fit | 4.05 |
ENST00000390615.2
|
immunoglobulin heavy variable 3-33 |
|
chr22_+_22880706 Show fit | 3.99 |
ENST00000390319.2
|
immunoglobulin lambda variable 3-1 |
|
chr19_+_41877267 Show fit | 3.81 |
ENST00000221972.8
ENST00000597454.1 ENST00000444740.2 |
CD79a molecule |
|
chr14_-_106235582 Show fit | 3.80 |
ENST00000390607.2
|
immunoglobulin heavy variable 3-21 |
|
chr2_-_89177160 Show fit | 3.57 |
ENST00000484817.1
|
immunoglobulin kappa variable 2-24 |
|
chr14_-_106062670 Show fit | 3.46 |
ENST00000390598.2
|
immunoglobulin heavy variable 3-7 |
|
chr14_-_105588322 Show fit | 3.38 |
ENST00000497872.4
ENST00000390539.2 |
immunoglobulin heavy constant alpha 2 (A2m marker) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 60.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 13.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 6.6 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 6.0 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.1 | 4.9 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 4.6 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.1 | 4.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 4.0 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 3.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.5 | 3.7 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 22.8 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.0 | 9.8 | GO:0072562 | blood microparticle(GO:0072562) |
1.3 | 7.6 | GO:0071745 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.1 | 5.9 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 5.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 4.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 4.0 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.8 | 3.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 3.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 3.3 | GO:0005604 | basement membrane(GO:0005604) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 43.9 | GO:0003823 | antigen binding(GO:0003823) |
0.4 | 26.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 15.6 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 5.0 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 4.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 4.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.6 | 3.8 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.2 | 3.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 3.7 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 3.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 8.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 6.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 5.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 4.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 4.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 3.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 3.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 2.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 2.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 10.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 6.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 4.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 3.8 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 3.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 2.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 2.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 2.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 1.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 1.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |